| Lipid quantification by Raman microspectroscopy as a potential biomarker in prostate cancer J O'Malley, R Kumar, AN Kuzmin, A Pliss, N Yadav, S Balachandar, ... Cancer letters 397, 52-60, 2017 | 50 | 2017 |
| Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous … S Balachandar, TJ Graves, A Shimonty, K Kerr, J Kilner, S Xiao, R Slade, ... American Journal of Medical Genetics Part A 188 (3), 959-964, 2022 | 42 | 2022 |
| Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells S Kumar, JR Inigo, R Kumar, AK Chaudhary, J O'Malley, S Balachandar, ... Cancer letters 413, 82-93, 2018 | 26 | 2018 |
| Defining the clinical validity of genes reported to cause pulmonary arterial hypertension CL Welch, MA Aldred, S Balachandar, D Dooijes, CA Eichstaedt, S Gräf, ... Genetics in Medicine 25 (11), 100925, 2023 | 14 | 2023 |
| Novel GDF2 loss of function variant in a family with HHT and PAVMs expands the phenotype associated with BMP9 dysfunction S Balachandar, T Graves, A Shimonty, S Xiao, R Slade, M Sroya, ... D25. O BRAVE NEW WORLD! OMICS, SYSTEM BIOLOGY, AND NEW MOLECULAR MECHANISMS …, 2020 | 1 | 2020 |
| Cybrid Analysis Delineates Nuclear and Mitochondrial Contributions to Oxidative Stress in Pulmonary Arterial Hypertension S Balachandar, TM OConnell, MA Aldred Circulation 148 (Suppl_1), A14665-A14665, 2023 | | 2023 |
